Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Human Molecular Genetics|August 24, 2005
Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disordersF Djouadi, F Aubey, D Schlemmer, et al.Journal of Inherited Metabolic Disease|June 10, 2006
Potential of fibrates in the treatment of fatty acid oxidation disorders: revival of classical drugs?F Djouadi, F Aubey, D Schlemmer, et al.American Journal of Human Genetics|April 17, 2007
Mutations in cytokine receptor-like factor 1 (CRLF1) account for both Crisponi and cold-induced sweating syndromesN Dagoneau, S Bellais, P Blanchet, et al.Clinical Pharmacology and Therapeutics|May 28, 2010
Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiencyJ P Bonnefont, J Bastin, P Laforêt, et al.American Journal of Human Genetics|November 14, 2007
Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapyS Gobin-Limballe, F Djouadi, F Aubey, et al.Clinical Genetics|September 13, 2008
Anderson's disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalitiesM Silvain, D Bligny, T Aparicio, et al.Pageof 3